Important note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.
|
|
AllAfrica (12.29.03) - Wednesday, December 31, 2003
Business Day
"[South African] provision of voluntary HIV/AIDS testing and counseling and treatment for sexually transmitted diseases and opportunistic infections is by no means ideal, but it is much poorer in Botswana," the report stated. The authors suggested that the apparent double standard results from Botswana subsidiaries being run as franchises. "The crossborder franchise relationship [is] fraught with vagueness about who has control over decision making, most critically in the area of HIV/AIDS," they wrote.
The study also said Botswana subsidiaries of South African firms use casual labor hired from a daily pool much more extensively than Botswana-based firms. Such laborers have no medical insurance, sick leave, or HIV/AIDS benefits, which leaves them very vulnerable.
The report also noted differences in how South African and Botswana companies perceived the potential effect of HIV/AIDS on their businesses. Botswana companies and subsidiaries were concerned about the epidemic's effect on their future financial sustainability, while South African companies were concerned about the direct costs of HIV/AIDS and its effect on productivity.
"There is a long way to go before any of the companies we studied approach compliance with the South African Development Community code on HIV/AIDS and employment, and by extension the various codes that apply to them in both countries," the study said.
031231
AD032703
Copyright © 2003 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.